Upfront intensive treatment analysis of the Italian Cohort Study on <i>FLT3</i>‐mutated AML patients (FLAM): The impact of a FLT3 inhibitor addition to standard chemotherapy in the real‐life setting

In conclusion, the benefit of FLT3i addition to upfront intensive treatment in newly diagnosed FLT3-mutated AML patients was confirmed in a large, real-life cohort study.

Authors

Institutions

Publication Details

Journal
Cancer
Published
2025-03-30
DOI
https://doi.org/10.1002/cncr.35824
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Upfront intensive treatment analysis of the Italian Cohort Study on FLT3‐mutated AML patients (FLAM): The impact of a FLT3 inhibitor addition to standard chemotherapy in the real‐life setting

Anna Candoni, Maria Teresa Bochicchio, Benedetta Cambò, Elisabetta Todisco et al.
Cancer
Acute Myeloid Leukemia Research
article

Upfront intensive treatment analysis of the Italian Cohort Study on FLT3‐mutated AML patients (FLAM): The impact of a FLT3 inhibitor addition to standard chemotherapy in the real‐life setting

Anna Candoni, Maria Teresa Bochicchio, Benedetta Cambò, Elisabetta Todisco, Attilio Olivieri, Emanuela Ottaviani, Daniela Cilloni, Giovanni Marconi, Elisabetta Petracci, Barbara Scappini, Roberta Volpi, Jacopo Nanni, Massimo Bernardi, Monica Bocchia, Gian Matteo Rigolin, Patrizia Chiusolo, Cristina Papayannidis, Monia Lunghi, Claudio Romani, Irene Valli, Francesco Albano, Federica Zamagni, Irene Azzali, Maria Benedetta Giannini, Maria Paola Martelli, Antonino Mulè, Nicola Stefano Fracchiolla, Ernesta Audisio, Agnese Mattei
article en

Abstract

In conclusion, the benefit of FLT3i addition to upfront intensive treatment in newly diagnosed FLT3-mutated AML patients was confirmed in a large, real-life cohort study.

CancerVol. 131(7)
University of Siena (IT), Università Cattolica del Sacro Cuore (IT), Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT), University of Parma (IT), University of Ferrara (IT), University of Perugia (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT), Azienda Ospedaliera di Perugia (IT), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT), Ospedale Vincenzo Cervello (IT), Ospedali Riuniti di Ancona (IT), Azienda Ospedaliero-Universitaria Careggi (IT), Istituto di Ematologia di Bologna (IT), Ospedale Santa Maria della Misericordia di Udine (IT), Ospedale di Circolo di Busto Arsizio (IT), IRCCS Ospedale San Raffaele (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Ospedale San Luigi Gonzaga (IT), St. Anna Hospital (DE), Azienda Ospedaliera G. Brotzu (IT), University of Bari Aldo Moro (IT), European Institute of Oncology (IT), University of Bologna (IT)
Openalex Percentile: Top 92%
Acute Myeloid Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.